Primary Research · 2019
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL trial)
Manson JE, Cook NR, Lee IM, et al. · New England Journal of Medicine, 2019
Key finding
Large primary-prevention RCT (n=25,871) found n-3 fatty acid supplementation did not reduce major cardiovascular events overall but did reduce myocardial infarction risk, with greatest benefit in low-fish-intake participants.
About the supplement
Omega-3 Fatty Acids
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/30415637/
Cited in 1 guide
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.